Anjan Drug Private Limited, a active private limited company, was established on 01 August 1990 in Chengalpattu Dt, Tamil Nadu, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231TN1990PTC019461. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹26.10 Cr and a paid-up capital of ₹5.88 Cr.
Formerly known as Anjan Drugs Private Limited. It upholds a compliant status. Employing 297 professional, Its leadership includes Vivek Chhachhi (Nominee Director), Chinnannan Kalaichelvan (Director), Santosh Kumar Mahil (Additional Director). Past directors included Divakar Madhusudan Gavaskar, Periyasamy Sivagnanam, Valliappan Venkatachalam. It holds ₹92.90 Cr open charges and ₹295.76 Cr settled loans. Its latest AGM occurred on 30 December 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.109 & 116,Sidcopharmaceutical I Estate,Alathur-603 110, Chengalpattu Dt, Tamil Nadu, 603110.
U24231TN1990PTC019461
019461
01 August 1990
₹26.10 Cr
₹5.88 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Anjan Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Chhachhi | Nominee Director | 09 Oct 2020 | Current |
| Chinnannan Kalaichelvan | Director | 01 Aug 1990 | Current |
| Santosh Kumar Mahil | Additional Director | 26 Jun 2025 | Current |
| Sumit Mohan Nadgir | Additional Director | 01 May 2025 | Current |
| Devi Thumati Krishnaraj | Additional Director | 28 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2018 | Past |
| Pramod Abcsdd | Director | 29 Feb 2016 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Additional Director | 11 Oct 2023 | Past |
| Pramod Abcsdd | Additional Director | 26 Jun 2025 | Past |
| Pramod Abcsdd | Additional Director | 11 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anjan Drug Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.61% increase. The company also saw a substantial improvement in profitability, with a 123% increase in profit. The company's net worth Soared by an impressive increase of 35.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Anjan Drug had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹929,000,000.00
₹2,957,563,600.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2022 | Others | ₹15.00 Cr | Open |
| 21 Oct 2021 | Hdfc Bank Limited | ₹31.20 Cr | Open |
| 01 Jun 2021 | Others | ₹15.00 Cr | Open |
| 22 Apr 2021 | Axis Bank Limited | ₹31.70 Cr | Open |
| 09 Jun 2022 | Hdfc Bank Limited | ₹14.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Anjan Drug has a workforce of 297 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Anjan Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anjan Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Santosh Kumar Mahil was appointed as a Additional Director was appointed as a Additional Director on 26 Jun 2025 & has been associated with this company since 6 months 21 days . was documented.
Sumit Mohan Nadgir was appointed as a Additional Director was appointed as a Additional Director on 01 May 2025 & has been associated with this company since 8 months 15 days . was recorded as a recent event.
Devi Thumati Krishnaraj was appointed as a Additional Director was appointed as a Additional Director on 28 Mar 2025 & has been associated with this company since 9 months 19 days . was recorded as a recent event.
The activity Anjan Drug Private Limited last Annual general meeting of members was held on 30 Dec 2024 as per latest MCA records. was completed.
Progress on Anjan Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Progress on A charge registered on 09 Jun 2022 via Charge ID 100584531 with Hdfc Bank Limited was fully satisfied on 15 Mar 2023. was documented.
The CIN of Anjan Drug Private Limited is U24231TN1990PTC019461.
Anjan Drug Private Limited is headquartered at Plot No.109 & 116,Sidcopharmaceutical I Estate,Alathur-603 110, Chengalpattu Dt, Tamil Nadu, 603110.
Anjan Drug Private Limited was incorporated on 01 August 1990.
The current directors of Anjan Drug Private Limited are
The primary industry of Anjan Drug Private Limited is Manufacturing.
Anjan Drug Private Limited is unlisted.
The authorized capital of Anjan Drug Private Limited is ₹26.10 Cr, and the paid-up capital is ₹5.88 Cr.
The compliance status of Anjan Drug Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX